CORC

在结果中检索

CORC

浏览/检索结果: 共524条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun
收藏  |  浏览/下载：122/0  |  提交时间：2022/11/21
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
收藏  |  浏览/下载：21/0  |  提交时间：2022/12/22
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文
THORACIC CANCER, 2022
作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/22
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches 期刊论文
PHARMACEUTICS, 2022, 卷号: 14
作者:  Ji, Qing;  Wu, Yuchen;  Albers, Andreas;  Fang, Meiyu;  Qian, Xu
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/22
First-in-human, phase I study of AK109, an anti-VEGFR2 antibody, in patients (pts) with advanced or metastatic solid tumors. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Xu, Nong;  Zheng, Yulong;  Zhong, Haijun;  Zhao, Fuyou;  Zhou, Huan
收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan
收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23
Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial 期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022
作者:  Li, Xinghui;  Shen, Jinwen;  Xia, Fan;  Zhu, Ji
收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge
收藏  |  浏览/下载：31/0  |  提交时间：2022/05/05
Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study 期刊论文
CANCER CELL INTERNATIONAL, 2021, 卷号: 21
作者:  Jin, Ya-Nan;  Qiang, Meng-Yun;  Liu, Meng-Meng;  Cheng, Zhi-Bin;  Zhang, Wang-Jian
收藏  |  浏览/下载：39/0  |  提交时间：2022/01/10
A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor 期刊论文
JOURNAL OF SEPARATION SCIENCE, 2021, 页码: 8
作者:  Zhou, Jun;  Zhan, Yan;  Zhong, Dafang;  Chen, Xiaoyan;  Zhang, Yifan
收藏  |  浏览/下载：72/0  |  提交时间：2021/11/04

©版权所有 ©2017 CSpace - Powered by CSpace